Ppp2r5d-related Neurodevelopmental Disorder

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-20
Clinical Trial Update: Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS]) [Phase 2]
Phase 2 trial update for Zatolmilast (BPN14770) in PPP2R5D-related neurodevelopmental disorder (Jordan's syndrome), noting the study is acti…